
Since the discovery of the double helix structure of DNA by James Watson and Francis Crick in 1953, mankind's exploration of the mysteries of life has entered a brand new era, and the publication of the human genome atlas in 2003 marked the official arrival of the genome sequencing era. In this technological revolution, genome sequencing technology has made continuous breakthroughs, from classic Sanger sequencing to high-throughput sequencing, and each advancement has greatly promoted the development of biology and medicine.
As a leading genome sequencing service provider in the industry, Tsingke gene factory has provided high-quality sequencing services to tens of thousands of clients with our outstanding technical strength and professional service team. Tsingke are equipped with the advanced 3730XL Genetic Analyzer, conducts structural and functional analysis of genomes. Tsingke are realizes the automation and intelligence of the entire process from sample processing to data generation, ensuring accuracy at every step and a sequencing success rate of over 99%. Meanwhile, genetic testing technology not only provides an important tool for scientific research, but also provides solid technical support for our core business - gene synthesis, ensuring the accuracy and reliability of gene synthesis.
Technical Strength
-FastNGS sequencing: For the special needs of small genome sequencing, Tsingke have innovatively introduced FastNGS sequencing technology. This technology not only dramatically increases the sequencing speed, but also significantly improves the accuracy and consistency of data, providing efficient support for gene synthesis.
The high accuracy of Sanger sequencing ensures precise genetic testing for applications requiring a high degree of accuracy. Tsingke\\\\\\\'s Genetic Analyzer automates the entire process.
Tsingke BioSignal analysis team has rich experience in multi-omics analysis, ensuring efficient analysis and interpretation of data, and providing comprehensive support from data generation to result analysis.
NGS can generate millions of short reads and long sequences in a single run, making it suitable for large-scale genome and transcriptome analyses, and Tsingke\\\\\\\'s illumina platform meets the needs of large-scale research.
NGS has a short turnaround time, from sample preparation to data generation in just a few days, improving research efficiency. Tsingke ensures that clients have timely access to data, providing fast and accurate services.
Third-generation sequencing technology can directly detect modified bases in DNA, such as methylation status, without additional processing steps.
Whole-exome sequencing captures and sequences only the exonic regions of the genome, and its genomic information accounts for about 1.5% of the entire genome size, and it can be used for SNP, InDel and CNV analyses, whereas whole-genome sequencing sequences the entire genome, and it can also be used for SV analyses. In addition, whole genome sequencing detects more comprehensive mutation information, not stopping at coding regions, but expanding to the entire non-coding regions. Mutations in non-coding regions have been increasingly studied in recent years and can be associated with the development of complex diseases, including many types of cancer.